In a Phase I clinical trial of ChronVac-C using Inovio’s MedPulser electroporation device the therapy resulted in increase in T-cell immune responses against HCV and was safe and
Under the pact, CTI is expected to initiate a Phase III trial in US and Europe in elderly patients with relapsed or refractory acute myeloid leukemia (AML) for
The company said that $30,000 grant has been awarded to Globe Laboratories, the licensor of the technology for this year and can be increased upon completion of preliminary
GLPG0187 was developed for metastatic cancer. In the trial, Galapagos expects to involve patients with solid tumor s and patients with confirmed diagnosis of advanced, recurrent, or metastatic
The company has posted a net loss of $8,929,000 for the third quarter 2011, or $0.14 loss per diluted share, compared to net loss of $1,538,000, or $0.03
FDA’s decision is supported by the identification of deficiencies in the conduct and design of the bioequivalence study which was submitted by the company in support of Pseudoephedrine
Upon recruitment, patients will be placed in one of four dose-escalating cohorts. Following completion of the dose escalation phase, the trial plan calls for a stable-dose phase in
As per the terms of the offer, Elanco would acquire products, manufacturing licenses, distribution rights and the existing contract portfolio, as well as the related intellectual property and
The tie up will enable MEDecision to help its healthcare payer and provider customers transition to, comply with and capitalize on the industry’s forthcoming ICD-10 requirements. As per
Halozyme has posted net loss of $16.89m, compared to a net loss of $12.66m, for the same period in 2009. The company’s operating loss was $17.88m for the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.